Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Primary Care
Is there any reason to stop mesalamine in a patient with UC undergoing breast/regional nodal radiation?
Answer from: Radiation Oncologist at Community Practice
I have run into this situation a few times and have not stopped mesalamine during breast radiation. Have not noticed any issues.
Sign In
or
Register
to read more
11392
Related Questions
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
When using surface image-guidance for breast radiation, how do you accommodate for changes in anatomy?
Is 5fx APBI and no endocrine therapy a new standard of care for women over 70 years old with low-risk breast cancer given the interim analysis of the EUROPA trial?
When using hypofractionated whole breast radiotherapy with a simultaneous integrated boost to the lumpectomy cavity, what IGRT strategy do you use?
Given the final publication of NSABP B-51, for which patients meeting trial eligibility would you still recommend regional nodal irradiation?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
How do your PMRT recommendations change with ITCs after neoadjuvant chemotherapy if they had SLNB only versus ALND in light of B51?
Would you treat a patient for heterotopic ossification prophylaxis if >72 hours after surgery?
Would you forgo lumpectomy cavity boost for grade 1 papillary carcinoma with associated grade 1 DCIS that has been resected with good margins?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?